Clinical Laserthermia Systems AB (CLS) Employee Directory

Medical Equipment ManufacturingEngland, United Kingdom11-50 Employees

Clinical Laserthermia Systems AB (CLSB) develops and markets the TRANBERG Thermal Therapy Systems, including the Thermoguide Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue and cancerous tumors, as well as treatment of drug-resistant epilepsy. The company also aims to extend approvals to interstitial laser thermotherapy for immunostimulatory ablation with potential abscopal effects. Headquartered in Lund, CLSB operates subsidiaries in Germany, the United States, and Singapore and is listed on the Nasdaq First North Growth Market under the CLS B symbol. Its products have regulatory approvals in the EU and the US. 

CLSB's target customers include clinicians in neurosurgery and oncology who perform minimally invasive laser ablation to treat soft tissue and tumors. In 2024 the company expanded its European presence by launching the TRANBERG system in France in collaboration with MTEC, indicating ongoing geographic and clinical expansion.

Sign up for free to view info

Company overview Email format